1. Home
  2. RPID vs ATRA Comparison

RPID vs ATRA Comparison

Compare RPID & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$1.66

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$9.41

Market Cap

81.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPID
ATRA
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.8M
81.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
RPID
ATRA
Price
$1.66
$9.41
Analyst Decision
Strong Buy
Sell
Analyst Count
1
2
Target Price
$8.00
$5.00
AVG Volume (30 Days)
222.2K
50.1K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
2.78
122.52
EPS
N/A
N/A
Revenue
$33,587,000.00
$120,772,000.00
Revenue This Year
$19.12
N/A
Revenue Next Year
$18.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.74
N/A
52 Week Low
$1.52
$3.92
52 Week High
$4.94
$19.15

Technical Indicators

Market Signals
Indicator
RPID
ATRA
Relative Strength Index (RSI) 38.58 56.62
Support Level N/A $9.03
Resistance Level $2.18 $11.17
Average True Range (ATR) 0.14 0.70
MACD -0.03 0.15
Stochastic Oscillator 20.59 83.08

Price Performance

Historical Comparison
RPID
ATRA

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Share on Social Networks: